EBITDA: Income before interest, taxes, depreciation and amortization.
Elevance Health, Inc. (ELV) had EBITDA of $3.02B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$50.18B |
|
$1.76B |
|
$41.08B |
|
$9.10B |
|
$47.52B |
|
$2.66B |
|
$-357.00M |
|
$2.30B |
|
$2.30B |
|
$1.76B |
|
$1.76B |
|
$1.76B |
|
$1.76B |
|
$2.66B |
|
|
EBITDA |
$3.02B |
219.80M |
|
220.40M |
|
$8.03 |
|
$8.00 |
|
| Balance Sheet Financials | |
$67.03B |
|
$4.66B |
|
$58.80B |
|
$125.83B |
|
$45.31B |
|
$30.77B |
|
$36.48B |
|
$81.78B |
|
$44.04B |
|
$4.61B |
|
$44.04B |
|
217.37M |
|
| Cash Flow Statement Financials | |
$4.33B |
|
$-1.64B |
|
$-2.52B |
|
$9.49B |
|
$9.66B |
|
$166.00M |
|
$55.00M |
|
$-376.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.48 |
|
-- |
|
-- |
|
0.41 |
|
0.72 |
|
18.14% |
|
5.30% |
|
5.30% |
|
-- |
|
4.59% |
|
3.52% |
|
$4.10B |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
-- |
|
2.20 |
|
40.87 |
|
4.00% |
|
38.19% |
|
1.40% |
|
2.35% |
|
$202.61 |
|
$18.59 |
|
$19.66 |
|